April 4, 2022 In the News AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals Read More +
January 21, 2022 Press Releases A timely reality check on silent pandemic of antimicrobial resistance Read More +
November 18, 2021 Media Pressure grows for market reforms to help tackle ‘silent pandemic’ of AMR Read More +
